This is a clinical decision and should be made with your provider the calculator will compute either the full or split volume
Patients with loose skin, loose muscles, or visceral (intra-abdominal) fat may need a diastasis repair instead of liposuction alone
IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
In a 48-week phase 2 trial published in The New England Journal of Medicine , adults with obesity (without type 2 diabetes) receiving once-weekly subcutaneous retatrutide at the 12 mg amount achieved a least-squares mean body weight reduction of 24.2%, compared with 2.1% in the placebo group [1]
Head-to-Head: What the Clinical Data Shows Comparing Retatrutide to Metformin requires acknowledging that direct head-to-head trials have not been published
Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss